Latest News for: multiple sclerosis

Edit

Virtual KOL Event to Discuss Glatiramer Acetate Once a Month Depot for the Treatment of Primary Progressive Multiple Sclerosis (Mapi-Pharma Ltd)

Public Technologies 13 Feb 2026
He was also the first Chairman of the multiple sclerosis section of the American Academy of Neurology and has participated in numerous clinical trials of new treatments for multiple sclerosis.
Edit

Canary Speech and Intermountain Ventures Launch Groundbreaking Study to Identify Multiple Sclerosis Using Vocal Biomarkers

Image Corvallis Gazette-Times 11 Feb 2026
Revolutionary AI-driven technology aims to transform MS diagnosis and improve patient outcomes with early detection ... .
Edit

Preventing Multiple Sclerosis from progressing to long-term disability

The Hindu 11 Feb 2026
The progression of MS symptoms to a disability is not a foregone conclusion. with the advancement of modern therapies, this cycle can be broken provided the condition is diagnosed early ....
Edit

TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis

Nasdaq Globe Newswire 08 Feb 2026
Campaign debuted during Super Bowl LX and introduced ...
Edit

Scientists find a missing link between Epstein-Barr virus and multiple sclerosis

Science Daily 07 Feb 2026
... virus may actively provoke the immune system in people with multiple sclerosis.
Edit

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) (Genentech Inc)

Public Technologies 07 Feb 2026
... multiple sclerosis [RRMS] and active, secondary progressive multiple sclerosis [SPMS], as well as clinically isolated syndrome [CIS] in the U.S.) and primary progressive multiple sclerosis (PPMS).
Edit

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

Pharmiweb 07 Feb 2026
... multiple sclerosis [RRMS] and active, secondary progressive multiple sclerosis [SPMS], as well as clinically isolated syndrome [CIS] in the U.S.) and primary progressive multiple sclerosis (PPMS).
Edit

TG Therapeutics Announces Presentation of Data for BRIUMVI� (ublituximab) in Multiple Sclerosis at the Americas ...

Nasdaq Globe Newswire 06 Feb 2026
... Sclerosis (ACTRIMS) annual forum, being held in San Diego, California.
Edit

Biogen Revenue Down as Multiple Sclerosis Sales Slide

Wall Street Journal 06 Feb 2026
Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments ... .
Edit

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis

Image Hastings Tribune 06 Feb 2026
... in Multiple Sclerosis (ACTRIMS) annual forum, being .
Edit

Multiple Sclerosis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight ...

GetNews 06 Feb 2026
“Multiple Sclerosis Pipeline Insight, 2025" ... Multiple Sclerosis current marketed and Multiple Sclerosis emerging therapies ... Multiple Sclerosis market drivers and Multiple Sclerosis market barriers.
Edit

Scientists find evidence of Epstein-Barr virus activity in spinal fluid of multiple sclerosis patients

PsyPost 06 Feb 2026
Emerging research has provided fresh evidence regarding the role of viral infection in the development of multiple sclerosis ... There is a strong epidemiological link between the Epstein-Barr virus and multiple sclerosis.
Edit

Forever chemicals boost multiple sclerosis risk. Is your water safe?

Image Hastings Tribune 05 Feb 2026
Could plastic byproducts and forever chemicals found ...
Edit

Backward walking study offers potential new treatment to improve mobility and decrease falls in multiple sclerosis patients (Wayne State University)

Public Technologies 04 Feb 2026
... the impact of a backward walking program on individuals with multiple sclerosis. The study, "Structural and Functional Changes With 8 Weeks of Backward Walking Training in Multiple Sclerosis.
Edit

What if multiple sclerosis isn't just one disease?

New Atlas 04 Feb 2026
For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology ... In everyday clinical care, multiple sclerosis is treated as a single disease with a broad variety of symptoms.

Article Search

tools
×
×
×
×